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Coronary angiography is the accepted standard for the di-
agnosis of coronary artery disease. The large number of
coronary angiograms performed yearly (estimated at 100
per 100,000 population in the United States in 1980[1])
suggests that many physicians maintain liberal indications
for coronary arteriography in coronary artery disease. Re-
cently, with the addition of intracoronary thrombolysis and
angioplasty, these numbers have increased and coronary
arteriography has advanced from a diagnostic procedure into
the realm of interventional cardiology.
Few would argue with the need for coronary arteriog-
raphy in patients with intractable symptoms receiving max-
imal medical therapy in whom coronary artery bypass graft-
ing is contemplated or in the symptomatic patient in whom
the diagnosis is unclear. However, these account for only
a small percent of patients with significant coronary artery
disease. In the remaining patients, the indications for coro-
nary arteriography are unresolved. Should all patients with
suspected coronary artery disease undergo angiography or
should it be restricted to patients who, by noninvasive test-
ing, have suspected multivessel or left main coronary in-
volvement? This editorial briefly reviews the data on prog-
nosis for patients in the different clinical subsets of coronary
artery disease and comments on the impact of noninvasive
studies and newer modalities of treatment (percutaneous
angioplasty and intracoronary thrombolysis) on the indi-
cations for coronary arteriography.
Stable Angina Pectoris
We learned that there exist both high and low risk subgroups
of patients with stable angina. Clinically, the presence of
hypertension, symptoms of congestive heart failure or a
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recent history of myocardial infarction are all associated
with a higher mortality rate in patients with stable angina
(2). Similarly, various abnormalities on the rest electrocar-
diogram, such as left ventricular hypertrophy, ST-T wave
changes, Q waves indicative of infarction or left ventricular
premature beats, are associated with an increased mortality
in patients with chronic stable angina (2,3). Early positive
results for ischemia or exertional hypotension on treadmill
testing also indicate a higher risk in this subset of patients
(4,5).
Coronary angiographic findings indicating high
risk. What has angiography taught us concerning the prog-
nosis of stable angina? Angiographic studies (6,7) have
identified the number of diseased vessels and the level of
left ventricular function as major determinants of prognosis
in chronic coronary artery disease. Therefore, the presence
of three vessel coronary artery disease, left main coronary
involvement or left ventricular dysfunction indicates an in-
creased risk of mortality in a patient with stable angina
which is, at least in part, independent of the clinical severity
of the symptoms (6).
Do these data indicate that all patients in a subset of
single or double or triple vessel disease should be treated
in the same fashion? Hutter (8) pointed out that the termi-
nology one, two or three vessel disease may be too restric-
tive as it does not take into account the degree of jeopardized
myocardium. For example, the patient with a single, 95%
proximal occlusion of a large left anterior descending artery
wrapping around the apex is probably at a higher risk than
a patient with a lesser degree of obstruction in the mid one-
third of a smaller left anterior descending coronary artery.
In the subset of patients with three vessel disease and normal
left ventricular function, the European Coronary Surgery
Study Group (9) found a poorer prognosis for patients re-
ceiving medical therapy when, in addition, there is an ab-
normal electrocardiogram at rest or 1.5 mm or more ST
depression on exercise testing. In addition, the morphology
of the coronary lesion is rarely taken into account in the
angiographic evaluation. In fact, there are no prospective
data on the relative risk of an irregular versus a smooth
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be associated with thrombus and myocardial infarction at
autopsy (10).
Indications for coronary angiography. What therefore
is the role of coronary arteriography in stable angina? In a
patient with mild stable angina (class I or II) and little or
no objective evidence of ischemia during exercise testing,
catheterization is unnecessary unless the diagnosis is unclear
and the patient or his physician, or both, feel compelled to
know the cause of the chest discomfort. In particular, this
might be the case in a young patient with multiple risk
factors for the development of coronary artery disease. Con-
versely, in the patient with poorly tolerated symptoms or
with marked ischemia on exercise or radionuclide stress
testing, coronary arteriography is essential in the evaluation
and management of the patient. It is for those patients with
less than either incapacitating symptoms or marked ischemia
on noninvasive testing that the decision for catheterization
must be individualized. In these patients, age, life style and
aspirations often dictate whether catheterization is recom-
mended.
The recently published results of the Coronary Artery
Surgery Study (CASS) (I I) show an excellent prognosis for
medical therapy in patients with orte, two or three vessel
disease and class I or II angina. The overall mortality rate
for medically treated patients was 1.6% per year and this
increased to 2.1 % per year for patients with three vessel
disease. However, in patients with I mm ST depression
who could exercise only into stage I, the annual mortality
rate for medically treated patients from the CASS registry
was at least 5% (12). Therefore, on the basis of these data
and those from other series indicating an increased risk for
subsequent myocardial events when early positive results
were present during exercise (4,13), it is reasonable to per-
form catheterization in these patients, even when their symp-
toms are mild.
When atypical chest pain is present, noninvasive testing
should be used, when feasible, to screen patients for cath-
eterization. A positive exercise test in association with an
abnormal exercise radionuclide study in a male or female
patient with an atypical chest pain syndrome is a valid in-
dication for catheterization to exclude obstructive coronary
artery disease as a cause of symptoms. The indication for
arteriography becomes even more obvious when, in addition
to these findings, there are one or more risk factors for the
presence of coronary disease.
Unstable Angina
Unstable angina, defined as the new onset of angina at
rest or at a low work load or a marked increase in frequency
and severity of stable angina, is a clear indication for coro-
nary arteriography unless surgery or angioplasty are refused
or contraindicated. The prognosis of unstable angina is worse
than that of stable angina, especially within the first weeks
to months after its onset (14,15). Additionally, in patients
treated medically, the majority of patients continue to ex-
perience disabling angina on follow-up study (16).
Implications. In our opinion, coronary arteriography
should be performed early, preferably during the same hos-
pitalization after medical stabilization has been attempted.
Not only will catheterization define the location and degree
of coronary stenosis in patients with coronary artery disease,
but it will also identify that small subgroup of patients with
normal epicardial coronary arteries (17). In the latter group,
noncardiac chest pain or occasionally coronary spasm will
be responsible for their symptoms. In the patient with an
unstable chest pain syndrome that is atypical for myocardial
ischemia, the physician must decide on clinical grounds as
to the probability of coronary artery disease as a cause of
the chest pain. If the probability is high, arteriography should
be performed early. Otherwise, in a patient with a low
probability of myocardial ischemia, catheterization can be
deferred and noninvasive tests for the presence of myo-
cardial ischemia performed.
Coronary Angioplasty
Coronary angioplasty has been established as an alter-
native to coronary artery bypass grafting in some patients
with coronary artery disease (18). However, its full thera-
peutic potential has yet to be attained. Recent advances in
angioplasty equipment have increased its effectiveness as a
therapeutic modality (19). Initially, a suitable lesion for
coronary angioplasty was a single, discrete, noncalcified
stenosis. Now, multivessel dilations are commonplace in
many institutions, and a calcified, segmental lesion can often
be successfully dilated and surgery avoided (20).
Indications for coronary angioplasty. The candidate
for coronary angioplasty should otherwise be a candidate
for coronary artery bypass grafting, and the indications for
this procedure should be similar. However, as proficiency
and experience with coronary angioplasty continue to in-
crease, a new patient category seems to be emerging-a
patient who is suitable for coronary angioplasty but who
otherwise would not usually be considered an appropriate
candidate for coronary artery bypass grafting. For example,
this might include a patient with severe symptoms but sig-
nificant systemic disease that might add to the risk of surgery
or a patient with mild symptoms but "favorable" lesions
for angioplasty. This philosophy, if generally accepted, could
drastically modify the indications for coronary arteriography
(and subsequent angioplasty) as physicians will endeavor to
identify potential candidates for this procedure by the liberal
Use of routine angiography. Additionally, the use of newer
technological advances like digital subtraction angiography
might increase the indications for angiography if the risk of
the procedure can be minimized by visualizing the coronary
arteries from a central aortic injection.






Another recent indication for coronary angiography has
been its application for coronary reperfusion in myocardial
infarction. As coronary angioplasty is changing the treat-
ment of patients with angina pectoris, intracoronary and
intravenous thrombolysis appear to be modifying the therapy
of acute myocardial infarction. Previous efforts to limit in-
farct size by decreasing myocardial oxygen demand, aug-
menting collateral blood flow or correcting ischemic cellular
defects have given way to techniques that increase myo-
cardial perfusion by clot lysis.
Role of intracoronary thrombolytic therapy. It is un-
clear, however, which patients will benefit from intra-
coronary thrombolytic therapy. Obviously, in a patient who
presents with extensive infarction, immediate reperfusion
within 3 to 4 hours of chest pain is likely to limit infarct
size (21,22). Nevertheless, it is too soon to recommend
reperfusion as routine therapy in all patients with acute
myocardial infarction until the results of on-going random-
ized clinical trials have been published. Will the ease of
administration permit intravenous agents to supersede in-
tracoronary administration? Does the risk of thrombolytic
therapy outweigh the potential benefit in patients with un-
complicated myocardial infarction without congestive heart
failure or with a normal or near normal left ventricular
ejection fraction? What is the time limit after the onset of
chest pain when reperfusion is unlikely to be of benefit?
These and other questions cannot be fully answered at pre~­
ent and, therefore, cloud the exact role of this form of
therapy in patients with acute myocardial infarction. Fur-
thermore, the development of newer and more effective
intravenous thrombolytic agents may, in the future, entirely
obviate the need for intracoronary administration. In any
event, identification of coronary artery anatomy early in the
course of infarction is essential to the application of th' ;e
methods and will widen the indications for coronary
arteriography.
Early revascularization surgery. Studies (23) of re-
vascularization surgery in the early stages of acute myo-
cardial infarction have demonstrated a low incidence of
morbidity and mortality from coronary arteriography and
coronary surgery in this group. However, the precise type
of patient in whom such an approach is necessary has not
been defined fully at this time.
Postmyocardial Infarction
In a patient with episodes of recurrent angina-like chest
pain after acute myocardial infarction in whom there is no
contraindication to surgery, catheterization is clearly indi-
cated because the prognosis of these patients is poor (24,25).
For patients with uncomplicated infarction without recurrent
chest pain, exercise stress testing in the recovery phase can
be used as a predictor of short-term morbidity and mortality
(26,27). The patients with an abnormal study are at a higher
risk for subsequent cardiac events. Such patients should be
considered candidates for cardiac catheterization in order to
identify the group in whom revascularization may be
beneficial.
Role of coronary angiography. A rational approach to
the management of the asymptomatic patient who has re-
covered from myocardial infarction has been presented by
Epstein et al. (28). According to their criteria, the asymp-
tomatic patient with adequate left ventricular function (an
ejection fraction 2: 30% by gated radionuclide scan) and a
normal exercise test does not require catheterization as mor-
tality is low. Nevertheless, routine coronary angiography is
recommended at many institutions for all young patients
after infarction to precisely define the coronary anatomy.
The definition of young is flexible, but should probably take
into account not only the chronologic age, but also the
physiologic status of the patient. We usually recommend
coronary angiography in all patients younger than 50 years
within 6 weeks of the acute infarction. Many of these pa-
tients can be studied within 3 weeks, before hospital dis-
charge. As one goal of the catheterization is to identify the
presence of potentially jeopardized myocardium, patients
with subendocardial infarction require special attention. About
30% of these patients will have a subtotal occlusion of the
left anterior descending artery (29) that may be suitable for
angioplasty. As coronary angiography can be safely per-
formed early after infarction (30), identification of the coro-
nary anatomy is an important aspect of therapy.
Sudden Death
The majority of patients who survive an episode of' 'sud-
den death" have not sustained an acute myocardial infarc-
tion (31). As the recurrence rate of cardiac arrest approaches
30% within the first year after the first episode, therapy in
survivors of sudden death should be aggtessive. Although
the role of coronary artery bypass grafting is unclear,
suppression of life threatening ventricular arrhythmias with
antiarrhythmic drug therapy is effective in preventing a re-
currence (32).
We usually recommend that in the absence of acute in-
farction, all survivors of sudden death should be considered
candidates for coronary arteriography. It is reasonable to
expect, although unproven, that in the presence of a large
area of jeopardized myocardium, revllscularization will im-
prove the long-term prognosis and should be considered in
addition to an effective antiarrhythmic regimen.
Asymptomatic Coronary Artery Disease
Painless ischemia is common in patients with either rest
or effort angina. The exact mechanism for the absence of
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pain in these patients is not well understood, but may relate
to a variable anginal pain threshold, alterations in pain per-
ception, the duration of the ischemic episode or the amount
of myocardium at risk. The incidence of completely asymp-
tomatic coronary artery disease is unknown, but has been
estimated at about 5% of middle-aged men (33). If angina
was always the first manifestation of coronary disease in
these patients, early recognition would not be essential.
However, if one can extrapolate from the Framingham data
(34), myocardial infarction and sudden death are common
presenting clinical manifestations of coronary artery disease,
occurring in 42 and 10% of men, respectively.
Prognosis. There are few data on the prognosis of com-
pletely asymptomatic coronary artery disease. In most stud-
ies dealing with asymptomatic patients with proven coronary
disease, the majority have become asymptomatic only after
myocardial infarction or are in a state of remission from
angina pectoris. Such patients are not comparable with the
completely asymptomatic patient. However, in a group of
78 airmen reported by Hickman et al. (35) with completely
asymptomatic coronary artery disease, 28% became symp-
tomatic within 7'/2 years of follow-up. In this group, angina
was the most common presentation, although four of their
patients sustained a myocardial infarction and two died
suddenly.
Other studies (36,37) examined the asymptomatic or min-
imally symptomatic patient (most patients had had a myo-
cardial infarction) and their data suggested a slightly better
prognosis than that in a more symptomatic group. However,
in these studies, patients with three vessel coronary disease
and either poor exercise tolerance or diminished left ven-
tricular function had a mortality rate of 9 and 5% per year,
respectively. Although patients in either the Coronary Ar-
tery Surgery Study or European trials were more sympto-
matic than those in the two studies just mentioned, the
prognosis for three vessel disease was much better, aver-
aging 2.1 % per year in the Coronary Artery Surgery Study
(II) and 3.5% per year in the European study (9). This
apparent improved prognosis for medical therapy of symp-
tomatic three vessel disease is not necessarily a reason to
change the indications for catheterization, but rather to re-
evaluate the need for bypass surgery.
Indications for coronary arteriography. Therefore,
catheterization appears warranted in patients with objective
evidence of significant ischemia at low work loads even
though they are asymptomatic or minimally symptomatic.
The purpose of catheterization is to identify those patients
with significant coronary artery disease, so that appropriate
therapy can be instituted if considered necessary. As the
predictive value of a positive exercise test in completely
asymptomatic patients varies with the age and sex of the
patient group studied, a confirmatory thallium exercise test
appears warranted in younger patients before considering
catheterization. In an older group of patients with an ab-
normal exercise test, coronary arteriography should be strongly
considered when the test is markedly abnormal and causes
for a false positive exercise study have been excluded.
Symptomatic Coronary Artery Disease After
Coronary Bypass Surgery
The widespread use of coronary artery bypass surgery
has caused the emergence of yet another patient subgroup
with coronary artery disease. The indications for repeat cath-
eterization in this group have not been clearly defined. How-
ever, it is reasonable to assume that the indications for
catheterization should be quite liberal. In some institutions,
all patients are routinely studied before discharge to deter-
mine the patency of the bypass grafts. As the great majority
of patients will have a marked lessening of symptoms, rou-
tine coronary arteriography is unnecessary in the asymp-
tomatic patient shortly after uncomplicated bypass surgery.
Indications for recatheterization. The reappearance of
angina within I year of operation is generally related either
to incomplete revascularization or graft stenosis or closure.
Early recatheterization is indicated, especially if graft ste-
nosis is suspected because in selected cases this may be
amenable to correction with either thrombolytic agents or
angioplasty (38,39). The later the reappearance of angina
after surgery, the more the indications for recatheterization
should closely approximate those for comparable patients
without prior surgery. In these patients, progression of coro-
nary artery disease as well as graft stenosis is likely to be
the cause of recurrent symptoms (40).
The indications for catheterization outlined above are
based on the following premises:
I. Revascularization by coronary artery bypass grafting
prolongs life in certain patient subgroups and improves
the symptomatic status of the patient. Although there is
still controversy on the former point, these indications
for catheterization are based on the premise that in se-
lected patients with either multivessel disease or large
areas of jeopardized myocardium, revascularization sur-
gery will prolong their life. The effects of coronary an-
gioplasty on survival in coronary artery disease have yet
to be determined, but it is likely that it will prolong life
in selected patient subgroups.
2. Age is not an absolute contraindication to coronary ar-
teriography or revascularization. Although the risk of
operation in patients older than 70 years of age is sig-
nificantly higher than in the younger patients (41), the
risk of catheterization is perhaps only slightly higher.
Catheterization can be safely performed in patients older
than 70 or 80 years. However, caution should be used
in recommending this procedure. It should only be con-
sidered when the patient has consented to the possibility
of coronary surgery or angioplasty and a reasonable med-
ical therapeutic regimen has failed.





Future developments. It is likely that the indications
for catheterization will change as new equipment becomes
available. The impact of newer invasive and noninvasive
techniques, such as digital subtraction angiography, nuclear
magnetic resonance imaging, computed axial tomography
and positron emission tomography, may well be important
in the future in modifying the need for standard coronary
arteriography in certain patients. However, at this time these
methods have not been evaluated adequately in large num-
bers of patients with different subsets of coronary artery
disease. Refinements in coronary angioplasty may expand
the indications for cardiac catheterization. New advances in
thrombolytic therapy will, most likely, alter the future in-
dications for coronary arteriography in patients with acute
myocardial infarction.
I express my appreciation to Ira J. Gelb, MD and Leslie A. Kuhn, MD
for their thoughtful review of the manuscript.
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